메뉴 건너뛰기




Volumn 2, Issue 4, 2005, Pages 182-183

What is the risk of second malignant neoplasms after childhood cancer?

Author keywords

Chemotherapy; Childhood cancer; Leukemia; Radiotherapy; Second malignant neoplasm

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; GYRASE INHIBITOR;

EID: 20444472784     PISSN: 17434254     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncponc0129     Document Type: Short Survey
Times cited : (4)

References (5)
  • 1
    • 0442307703 scopus 로고    scopus 로고
    • High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group
    • Bhatia S et al. (2003) High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group. J Clin Oncol 21: 4386-4394
    • (2003) J. Clin. Oncol. , vol.21 , pp. 4386-4394
    • Bhatia, S.1
  • 2
    • 0027500844 scopus 로고
    • Second malignant neoplasms after cancer in childhood or adolescence
    • Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries
    • Olsen JH et al. (1993) Second malignant neoplasms after cancer in childhood or adolescence. Nordic Society of Paediatric Haematology and Oncology Association of the Nordic Cancer Registries. Br Med J 307: 1030-1036
    • (1993) Br. Med. J. , vol.307 , pp. 1030-1036
    • Olsen, J.H.1
  • 3
    • 0035906222 scopus 로고    scopus 로고
    • Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study
    • Neglia JP et al. (2001) Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93: 618-629
    • (2001) J. Natl. Cancer Inst. , vol.93 , pp. 618-629
    • Neglia, J.P.1
  • 4
    • 0033008437 scopus 로고    scopus 로고
    • Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins
    • Smith MA et al. (1999) Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins. J Clin Oncol 17: 569-577
    • (1999) J. Clin. Oncol. , vol.17 , pp. 569-577
    • Smith, M.A.1
  • 5
    • 16644394450 scopus 로고    scopus 로고
    • Development of risk-based guidelines for pediatric cancer survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline
    • Landier W et al. (2004) Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol 22: 4979-4990
    • (2004) J. Clin. Oncol. , vol.22 , pp. 4979-4990
    • Landier, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.